Harshman, Lauren C.

Effect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell Carcinoma

Lalani, A.-K. A., Xie, W., Braun, D. A., Kaymakcalan, M., Bossé, D., Steinharter, J. A., Martini, D. J., Simantov, R., Lin, X., Wei, X. X., et al. (2020) · European Urology Oncology

Renal cell carcinoma treatmentCancer Immunotherapy and Biomarkers

Cited by 100

Association of immune-related adverse events (irAEs) with clinical benefit in patients with metastatic urothelial carcinoma (mUC) treated with immune-checkpoint inhibitors (ICIs).

Pier Vitale, N., Pond, G. R., Abou Alaiwi, S., Nassar, A., Flippot, R., Choueiri, T. K., Harshman, L. C., & Sonpavde, G. (2019) · Journal of Clinical Oncology

Cancer Immunotherapy and BiomarkersBladder and Urothelial Cancer Treatments

Cited by 4